Laura Deming

“I believe in a bright and limitless future - I believe it is not certain, but a product of the choices we make.”
Longevity
Biolotechnology
Philosophy

Laura has been focusing on life extension and using biological research to reduce or reverse the effects of aging. She is a partner at The Longevity Fund, channeling investments into groundbreaking approaches to combat aging-related diseases, and a co-founder of Age1, a venture-capital firm targeting life sciences startups that have technologies designed to help people live longer and healthier lives. She has also founded a pioneering accelerator and advises on projects seeking to unearth talent in longevity through the Pioneer fund. 

Laura recognized the inevitability of aging's toll when she was 8 years old and immersed herself in biogerontology at 12. She entered MIT at 14 and, at 17, was awarded a 20under20 fellowship by Peter Thiel, propelling her venture into longevity research. Forbes' "30 Under 30" and National Geographic's documentaries highlight her trailblazing journey.